Membrane adsorption of endocrine disrupting compounds and pharmaceutically active compounds

Adsorption is one of the main mechanisms contributing to compound removal by membrane filtration, in addition to size exclusion and charge repulsion. In this study, the adsorption of 22 endocrine disrupting compounds and pharmaceutically active compounds by ultrafiltration (UF), nanofiltration (NF) and reverse osmosis (RO) membranes was investigated using 24-h bottle tests at 21 and 4 °C. Two natural waters (Lake Ontario and effluent from a membrane bioreactor (MBR)) and one laboratory-grade water were examined. Adsorption was strongly correlated with compound log Kow and membrane pure water permeability, and moderately correlated with compound water solubility. Adsorption was observed to be highest by the UF membrane followed by the NF and RO membranes. The influence of temperature on adsorption in the range examined was found to be insignificant. Three compounds for which deuterium-labelled surrogates were available (acetaminophen, carbamazepine, gemfibrozil) were examined to determine the influence of water matrix on adsorption. Adsorption of gemfibrozil may have been hindered due to competition for adsorption sites from the organic matter present in the lake water and MBR effluent.